12:00 AM
Jul 27, 2009
 |  BC Week In Review  |  Company News  |  Other News

Genzyme metabolic news

Genzyme will move the manufacturing of alglucosidase alfa to its 4,000-liter scale facility in Belgium from its 2,000-liter scale facility in Allston, Mass. The Allston facility, which closed in June due to viral contamination, will make only Cerezyme imiglucerase to treat Type I Gaucher's...

Read the full 207 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >